Screening Europe - HTS & Compound Management

Agenda Topics

• Automation in Screening
• Chemical Probes
• Compound Management
• Fragment Based Drug Discovery
• High Content Screening
• Label-Free Assays

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44 (0) 1206 501654

Confirmed Speakers to date

, ,
Martin Augustin, Technology Manager, Merck Millipore
Holger Eickhoff, Chief Executive Officer, Scienion AG
Richard Ellson, Chief Technology Officer, Labcyte Inc
Brian Everatt, Research Investigator, Novartis
Alexander Frittrang, Key Account Manager, Thermo Scientific
Stefan Geschwindner, Principal Scientist, AstraZeneca R&D Molndal
Carsten Grotzinger, Group Leader/Head, Charite University Medicine Berlin
Sheraz Gul, Vice President & Head, European Screening Port GmbH
Doris Hafenbradl, Senior Director, Biofocus
David Harding, Head of Sales, Brooks Life Science Systems
Peter Horvath, Finnish Distinguished Professor, Fellow FIMM Helsinki and Group Leader, Hungarian Academia of Sciences
Susanne Reichenberger, Product Specialist, Thermo Scientific
Larry Sklar, Director, University of New Mexico Health Sciences Center
Dirk Sombroek, Scientist, BRAIN Biotechnology Research And Information Network
Fredrick Sundberg, Director of Global Pharma Market Development, GE Healthcare
Kerstin Thurow, Chief Executive Officer, Center for Life Science Automation
Jens Peter von Kries, Head of Screening, FMP/Leibniz Institute for Molecular Pharmacology
Toby Winchester, Application Consultant, Titian Software